Skip to main content
. 2020 Jan 17;12(1):228. doi: 10.3390/cancers12010228

Figure 3.

Figure 3

Viral replication of OTS-412 in tumor-bearing mouse models. (A) Tumor scan using bioluminescence assay conducted two days post single-dose intratumoral (IT) injection of saline (S1), VV-tk deleted oncolytic vaccinia virus (VVtk-) (1 × 107 PFU, S2, and S3), and OTS-412 (1 × 107 PFU, S4, and S5) in syngeneic RenCa tumor-bearing mice. Green diamonds (S1–S4) and red diamond (S5) in the tumor center are indicators of region of interest. (B) Quantification of the luciferase signal showing no statistical difference between the VVtk- and OTS-412 treated mice.